DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+4.82%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.25B
AUM Growth
+$2.25B
(+3.1%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
37.85%
Holding
149
New
29
Increased
29
Reduced
29
Closed
26
Top Buys
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$74.2M |
| 2 |
eHealth
EHTH
|
$40M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$38.2M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$37M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
$32.3M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$94.5M |
| 2 |
Labcorp
LH
|
$57.2M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$32.1M |
| 4 |
AbbVie
ABBV
|
$27.3M |
| 5 |
Merck
MRK
|
$27.1M |
Sector Composition
| 1 | Healthcare | 46.87% |
| 2 | Financials | 2.85% |
| 3 | Technology | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBX
76
DELISTED
CYBERONICS INC
CYBX
| $3.43M | 0.14% |
+54,890
| New | +$3.43M |
|
|
VIRX
77
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.3M | 0.13% |
505,741
+50,000
| +11% | +$326K |
|
|
NSPH
78
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $3.16M | 0.13% |
2,000,000
| – | – |
|
|
LMNS
79
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
| $2.91M | 0.12% |
+298,966
| New | +$2.91M |
|
|
VYNT
80
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $2.36M | 0.09% |
208,914
-109,098
| -34% | -$1.23M |
|
|
OCRX
81
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2M | 0.08% |
261,119
| – | – |
|
|
PTN
82
DELISTED
Palatin Technologies
PTN
| $1.98M | 0.08% |
2,000,000
| – | – |
|
|
QCOR
83
DELISTED
QUESTCOR PHARMA INC
QCOR
| $1.61M | 0.06% |
17,443
-1,022,422
| -98% | -$94.5M |
|
|
AMED
84
DELISTED
Amedisys
AMED
| $1.36M | 0.05% |
81,399
-357,601
| -81% | -$5.99M |
|
85
Select Medical
SEM
$1.6B
| $1.34M | 0.05% |
+85,621
| New | +$1.34M |
|
|
SPPI
86
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.29M | 0.05% |
159,122
-1,106,253
| -87% | -$9M |
|
87
AstraZeneca
AZN
$255B
| $929K | 0.04% |
+12,500
| New | +$929K |
|
|
AGRX
88
DELISTED
Agile Therapeutics, Inc
AGRX
| $904K | 0.04% |
+103,613
| New | +$904K |
|
89
Neurocrine Biosciences
NBIX
$13.5B
| $788K | 0.03% |
53,094
-24,900
| -32% | -$370K |
|
|
OSIR
90
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $679K | 0.03% |
+43,445
| New | +$679K |
|
91
Smith & Nephew
SNN
$16.2B
| $670K | 0.03% |
+7,500
| New | +$670K |
|
92
TherapeuticsMD
TXMD
$12.7M
| $492K | 0.02% |
111,214
-264,835
| -70% | -$1.17M |
|
93
Icon
ICLR
$14B
| $471K | 0.02% |
+10,000
| New | +$471K |
|
|
IMRS
94
DELISTED
IMRIS INC COMMON SHARES (CANADA)
IMRS
| $460K | 0.02% |
+407,392
| New | +$460K |
|
95
Prothena Corp
PRTA
$452M
| $451K | 0.02% |
+20,000
| New | +$451K |
|
96
Tenax Therapeutics
TENX
$27.5M
| $446K | 0.02% |
109,262
-440,738
| -80% | -$2.08M |
|
97
Perrigo
PRGO
$3.21B
| $364K | 0.01% |
+2,500
| New | +$364K |
|
98
Opko Health
OPK
$1.1B
| $332K | 0.01% |
+37,500
| New | +$332K |
|
|
MDRX
99
DELISTED
Veradigm Inc. Common Stock
MDRX
| $289K | 0.01% |
+18,000
| New | +$289K |
|
100
Precipio
PRPO
$25.6M
| $266K | 0.01% |
+71,086
| New | +$266K |
|